Skip to main content
. 2021 Jan;10(1):326–335. doi: 10.21037/tau-20-1066

Figure 1.

Figure 1

Kaplan-Meier analysis for overall survival (OS) in patients with ccRCC. (A) OS for patients with CD3+ T cells; (B) OS for patients with CD4+ T cells; (C) OS for patients with CD8+ T cells; (D) OS for patients with CD4+/CD8+ ratio.